Cited by 138Histone Deacetylase Inhibitors ResearchGenomics and Chromatin DynamicsEpigenetics and DNA Methylation

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; none of the 46 sources its claims cite is checked for support yet.

Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo

Open access

Abstract

Proteomic analysis of histones has shown that they are subject to a superabundance of acylations, which extend far beyond acetylation, to include: crotonylation, propionylation, butyrylation, malonylation, succinylation, β-hydroxybutyrylation and 2-hydroxyisobutyrylation. To date, much of the functional data has focussed on histone crotonylation which, similar to acetylation, has been associated with positive gene regulation and is added by the acyltransferase, p300. Although Sirtuins 1–3, along with HDAC3, have been shown to possess decrotonylase activity in vitro, there is relatively little known about the regulation of histone crotonylation in vivo. Here we show that Histone Deacetylase 1 and 2 (HDAC1/2), the catalytic core of numerous co-repressor complexes, are important histone decrotonylase enzymes. A ternary complex of HDAC1/CoREST1/LSD1 is able to hydrolyse both histone H3 Lys18-acetyl (H3K18ac) and H3 Lys18-crotonyl (H3K18cr) peptide substrates. Genetic deletion of HDAC1/2 in ES cells increases global levels of histone crotonylation and causes an 85% reduction in total decrotonylase activity. Furthermore, we mapped H3K18cr in cells using ChIP-seq, with and without HDAC1/2, and observed increased levels of crotonylation, which largely overlaps with H3K18ac in the vicinity of transcriptional start sites. Collectively, our data indicate that HDAC1/2 containing complexes are critical regulators of histone crotonylation in vivo.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

HDAC1/2-containing complexes act as histone decrotonylases in vitro and in mouse ES cells; deletion of HDAC1/2 increases global H3K18ac and H3K18cr and reduces total decrotonylase activity by 85%. ChIP-seq shows H3K18cr overlaps H3K18ac near transcription start sites and increases at active/bivalent genes upon HDAC1/2 loss.

Key findings

  • A recombinant HDAC1/CoREST1/LSD1 ternary complex hydrolysed both H3K18ac and H3K18cr peptides, with a lower initial rate for decrotonylation than deacetylation; InsP6 increased the initial deacetylation rate 3.2-fold and decrotonylation rate 1.8-fold. HDAC3/SMRT/GPS2/TBL1 also showed decrotonylase activity, with an initial rate 2.4-fold lower for H3K18cr than H3K18ac.
  • In ES cells, LBH589 treatment increased H3K18cr 3.2-fold and H3K18ac 2.6-fold in a dose-dependent manner; both marks doubled within 2 hours.
  • HDAC1/2 double knockout ES cells showed 2.3-fold higher H3K18ac and 2.2-fold higher H3K18cr, plus 1.8-fold higher total H3 crotonylation and 1.7-fold higher H4 crotonylation; total decrotonylase activity was reduced by 85%, while deacetylase activity was 56% of control.
  • ChIP-seq in control and HDAC1/2 DKO ES cells showed H3K18cr peaks near TSS overlapping H3K18ac; loss of HDAC1/2 increased average H3K18ac and H3K18cr around TSS, with up to 4-fold increases in H3K18cr at loci such as Lactb and Anapc5, and increased H3K18cr correlated with upregulated genes (p < 0.0001) and GO enrichment overlap (R² = 0.929, p < 0.0001).

Methods

  • In vitro deacetylase/decrotonylase assays used Caliper EZ Reader II with 500 nM recombinant HDAC1/CoREST1/LSD1 or HDAC3/SMRT/GPS2/TBL1 complexes and fluorescein-labelled H3K18ac, H3K18cr, and H4K16ac peptides, with or without InsP6.
  • Cell assays used mouse ES cells and HEK-293T cells; conditional Hdac1/2 deletion was induced with 1 µM tamoxifen (OHT), HDAC inhibition with LBH589, and activity measured with Boc-Lys(Ac)-AMC and Boc-Lys(Cr)-AMC substrates, plus quantitative western blotting and co-immunoprecipitation with HDAC2/LSD1 antisera.
  • ChIP-seq for H3K18ac and H3K18cr was performed in control and DKO ES cells using native ChIP and Illumina HiSeq4000 75 bp sequencing; reads were mapped to mm9, peaks called with MACS, and analyses used deepTools and DAVID, with data deposited at GEO GSE116019.

Limitations

  • Paper-stated: prior in vitro studies with isolated recombinant enzymes may not reflect physiological activity, and class-I HDAC activity in vivo depends on binding to complex partners; the paper also notes that in vitro decrotonylation was slower than deacetylation, whereas cellular recovery showed little difference, possibly due to isolated histone-tail peptides versus intact nucleosomes or cooperating factors.
  • Evident: the in vitro assays use peptide substrates rather than intact nucleosomes, and the genetic and ChIP-seq findings are largely in mouse ES cells, so generalizability to other cell types or tissues is not established here.
  • Evident: some in vitro data are from n = 2 technical replicates (Fig. 1), and although HDAC3 knockout showed no significant global change in H3K18ac/H3K18cr, the paper states this does not preclude locus-specific regulation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41598-018-32927-9

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 HDAC1 functions as a histone decrotonylase whose activity is modulated by inositol phosphates. Deacetylase and decrotonylase activities were measured using a Caliper assay with continuous substrate turnover for a 60 min period. Analogous H3K18ac (A), H3K18cr (B) and H4K16ac (C) fluorescein-tagged peptides were incubated with recombinant HDAC1/CoREST1/LSD1 ternary complex. Graphs show the average percentage conversion (mean ± SD; n = 2), initial rates and percentage conversion of substrate at the end point ±100 μM InsP6 (D-myo-inositol 1, 2, 3, 4, 5, 6-hexakisphosphate).
Figure 1 HDAC1 functions as a histone decrotonylase whose activity is modulated by inositol phosphates. Deacetylase and decrotonylase activities were measured using a Caliper assay with continuous substrate turnover for a 60 min period. Analogous H3K18ac (A), H3K18cr (B) and H4K16ac (C) fluorescein-tagged peptides were incubated with recombinant HDAC1/CoREST1/LSD1 ternary complex. Graphs show the average percentage conversion (mean ± SD; n = 2), initial rates and percentage conversion of substrate at the end point ±100 μM InsP6 (D-myo-inositol 1, 2, 3, 4, 5, 6-hexakisphosphate).CC BY · PubMed Central
Figure 2 HDAC inhibition increases both H3K18ac and H3K18cr in a dose-dependent manner. (A) Deacetylase and (B) decrotonylase activities were measured using increasing concentrations of whole-cell extracts from mouse ES and HEK-293T cells using Boc-Lys(Ac)-AMC and BOC-Lys(Cr)-AMC substrates. Average plots of n = 3 technical replicates. ES cells were treated with either, increasing concentrations of LBH589 for 24 hrs (C), or treated with 50 nM of LBH589 for indicated time (D), before histones were extracted and subjected to quantitative western blotting using an Odyssey scanner. Levels of H3K18ac and H3K18cr were normalized to the level of histone H3 and graphs show the average normalized signal intensity (mean ± SEM; n ≥ 3). Uncropped scans of western blot gels are in Supplementary Fig. 2A,B.
Figure 2 HDAC inhibition increases both H3K18ac and H3K18cr in a dose-dependent manner. (A) Deacetylase and (B) decrotonylase activities were measured using increasing concentrations of whole-cell extracts from mouse ES and HEK-293T cells using Boc-Lys(Ac)-AMC and BOC-Lys(Cr)-AMC substrates. Average plots of n = 3 technical replicates. ES cells were treated with either, increasing concentrations of LBH589 for 24 hrs (C), or treated with 50 nM of LBH589 for indicated time (D), before histones were extracted and subjected to quantitative western blotting using an Odyssey scanner. Levels of H3K18ac and H3K18cr were normalized to the level of histone H3 and graphs show the average normalized signal intensity (mean ± SEM; n ≥ 3). Uncropped scans of western blot gels are in Supplementary Fig. 2A,B.CC BY · PubMed Central
Figure 3 HDAC1/2 are the dominant histone decrotonylases in ES cells. (A) The decrotonylase activity of HDAC1/2 complexes isolated from ES cells, using antisera to HDAC2 and LSD1, were measured using a Boc-Lys(Cr)-AMC substrate. No cell lysate (neg) and normal mouse IgG were used as negative controls. Average (±SD) plots of n = 3 technical replicates. (B) Quantitative western blot data for the indicated proteins in Ctrl (day 0) and DKO ES cells treated with 4-hydroxytamoxifen (OHT) at day 3, were performed using an Odyssey scanner. Graphs show the average normalized signal intensity (mean ± SEM; n ≥ 3) relative to Histone H3. Uncropped scans of western blots are shown in Supplementary Fig. 3A–C. (C) Deacetylase and (D) decrotonylase assays were performed using whole-cell extracts from Ctrl (day 0) and DKO ES cells (day 3, following OHT treatment). Average (±SD) plots of n = 3 technical replicates. (E) Changes in both deacetylase and decrotonylase activity in DKO ESCs were calculated as a percentage of CTRL ES cells from the values depicted in (C) and (D).
Figure 3 HDAC1/2 are the dominant histone decrotonylases in ES cells. (A) The decrotonylase activity of HDAC1/2 complexes isolated from ES cells, using antisera to HDAC2 and LSD1, were measured using a Boc-Lys(Cr)-AMC substrate. No cell lysate (neg) and normal mouse IgG were used as negative controls. Average (±SD) plots of n = 3 technical replicates. (B) Quantitative western blot data for the indicated proteins in Ctrl (day 0) and DKO ES cells treated with 4-hydroxytamoxifen (OHT) at day 3, were performed using an Odyssey scanner. Graphs show the average normalized signal intensity (mean ± SEM; n ≥ 3) relative to Histone H3. Uncropped scans of western blots are shown in Supplementary Fig. 3A–C. (C) Deacetylase and (D) decrotonylase assays were performed using whole-cell extracts from Ctrl (day 0) and DKO ES cells (day 3, following OHT treatment). Average (±SD) plots of n = 3 technical replicates. (E) Changes in both deacetylase and decrotonylase activity in DKO ESCs were calculated as a percentage of CTRL ES cells from the values depicted in (C) and (D).CC BY · PubMed Central
Figure 4 Loss of HDAC1/2 leads to a global increase in H3K18cr and H3K18ac. (A) Average ChIP coverage levels of H3K18ac and H3K18cr in Ctrl and DKO ES cells at transcriptional start sites (TSS) 5,000 bp upstream and downstream. (B) ChIP-seq density heatmaps in Ctrl and DKO ES cells for H3K18ac and H3K18cr at TSS ±5,000 bp, ranked by increase in acetylation or crotonylation following Hdac1/2 deletion. Red dotted line indicates the top 10% of genes enriched for H3K18ac and H3K18cr. (C) Heatmap of HDAC1 and 2 densities [as defined in Whyte et al.38] at TSS sites ±5,000 bp ranked by H3K18cr levels in Ctrl cells. (D) IGV enrichment tracks of H3K18ac and H3K18cr at the three representative genes: Rps27l, Lactb and Anapc5. The gene structure and dimensions are indicated in each panel.
Figure 4 Loss of HDAC1/2 leads to a global increase in H3K18cr and H3K18ac. (A) Average ChIP coverage levels of H3K18ac and H3K18cr in Ctrl and DKO ES cells at transcriptional start sites (TSS) 5,000 bp upstream and downstream. (B) ChIP-seq density heatmaps in Ctrl and DKO ES cells for H3K18ac and H3K18cr at TSS ±5,000 bp, ranked by increase in acetylation or crotonylation following Hdac1/2 deletion. Red dotted line indicates the top 10% of genes enriched for H3K18ac and H3K18cr. (C) Heatmap of HDAC1 and 2 densities [as defined in Whyte et al.38] at TSS sites ±5,000 bp ranked by H3K18cr levels in Ctrl cells. (D) IGV enrichment tracks of H3K18ac and H3K18cr at the three representative genes: Rps27l, Lactb and Anapc5. The gene structure and dimensions are indicated in each panel.CC BY · PubMed Central
Figure 5 Loss of HDAC1/2 regulates H3K18cr levels associated with active gene expression. Average levels of H3K18ac and H3K18cr in Ctrl and DKO ES cells: (A) at upregulated genes following the loss of HDAC1/2 [as defined in Jamaladdin et al.29]; and (B) genes associated with bivalent histone signatures [as defined in Mikkelsen et al.36]. Acetylation level was calculated using DEEPTOOLS for each promoter, defined as the region between ±500 bp of the TSS, and presented in log2 scale. (C) Functional annotation analysis of the top 10% of genes enriched for either H3K18cr or H3K18ac (Fig. 4B; red line). DAVID was used to identify biological process (BP) and gene ontology (GO). (D) Regression analysis of false discovery rate (FDR) from enriched GO terms for both H3K18ac and H3K18cr. Data presented in log10 scale.
Figure 5 Loss of HDAC1/2 regulates H3K18cr levels associated with active gene expression. Average levels of H3K18ac and H3K18cr in Ctrl and DKO ES cells: (A) at upregulated genes following the loss of HDAC1/2 [as defined in Jamaladdin et al.29]; and (B) genes associated with bivalent histone signatures [as defined in Mikkelsen et al.36]. Acetylation level was calculated using DEEPTOOLS for each promoter, defined as the region between ±500 bp of the TSS, and presented in log2 scale. (C) Functional annotation analysis of the top 10% of genes enriched for either H3K18cr or H3K18ac (Fig. 4B; red line). DAVID was used to identify biological process (BP) and gene ontology (GO). (D) Regression analysis of false discovery rate (FDR) from enriched GO terms for both H3K18ac and H3K18cr. Data presented in log10 scale.CC BY · PubMed Central

Verification

Claims the paper makes

41 Own result · 28 Not checked yet · 7 Own interpretation · 1 Own method · 1 No basis given

Verify all 46 references — free account

Show all 46 claims

  • It may state two separate claims as one. 21
  • Probably not a substantial claim. 16
32 of 32
  • The paper relies on this without support.

    The HDAC1/CoREST1/LSD1 ternary complex is representative of HDAC1/2-containing co-repressor complexes for decrotonylase activity.

    “For this study we utilized the CoREST complex because we are able to generate a recombinant HDAC1/CoREST1/LSD1 ternary complex23, using full-length proteins, in a 1:1:1 ratio at milligram quantities.”
  • The paper relies on this without support.

    ES cells are a valid model for in vivo regulation of histone crotonylation.

    “Collectively, our data indicate that HDAC1/2 containing complexes are critical regulators of histone crotonylation in vivo.”
  • The paper relies on this without support.

    The changes in histone crotonylation levels upon HDAC1/2 deletion are due to loss of HDAC1/2 decrotonylase activity rather than indirect effects on other enzymes.

    “Since these observations imply HDAC1/2 are active decrontonylases, we assayed the remaining deacetylase and decrotonylase activity following HDAC1/2 deletion.”
  • The paper relies on this without support.

    The H3K18cr antibody used for native ChIP specifically detects H3K18cr.

    “Chromatin was immunoprecipitated using 8 μg H3K18ac (Catalog No: 39755; Active Motif) or 8 μg H3K18cr (PTM-Biolabs 517) conjugated to 50 μL Dynabeads Protein G overnight at 4 °C.”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Cited by

Sorted by citations

Items 101–138 of 138

Metadata

Authors
Kelly, R. D. W., Chandru, A., Watson, P. J., Song, Y., Blades, M., Robertson, N. S., Jamieson, A. G., Schwabe, J. W. R., & Cowley, S. M.
Affiliations
  • University of Leicester (GB)
  • University of Cambridge (GB)
  • University of Glasgow (GB)
Corresponding author
Cowley, S. M.
Venue
Scientific Reports
Published
2018-10-02
Volume
8
Issue
1
Pages
14690-14690
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2892763111
Cited by
138
References
49
Citations by year
2026: 13 · 2025: 20 · 2024: 25 · 2023: 17 · 2022: 19 · 2021: 21 · 2020: 12 · 2019: 11
FWCI
3.91
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • Engineering and Physical Sciences Research Council (EP/N034260/1)
  • Wellcome Trust (100237)
  • Biotechnology and Biological Sciences Research Council (BB/N002954/1, BB/P021689/1)
  • Medical Research Council (MR/J009202/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
HDAC1, HDAC2, histone crotonylation, histone acetylation, LSD1, H3K18, histone acylation, corepressor complex, epigenetic regulation, embryonic stem cells
MeSH terms
Cell Line, Histones, Humans, Multienzyme Complexes, Protein Processing, Post-Translational, Histone Deacetylase 1, Histone Deacetylase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review